The inducing effect of agonist anti-CD40 mAb 5C11 on leukemic dendritic cells

被引:0
|
作者
Wang, Z [1 ]
Gu, Y [1 ]
Zhang, X [1 ]
机构
[1] Soochow Univ, Inst Biotechnol, Suzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
471
引用
收藏
页码:217 / 218
页数:2
相关论文
共 50 条
  • [41] ANTI-CD40 AGONIST MABS MEDIATE ACTIVATION AND RECRUITMENT OF BOTH INNATE AND ADAPTIVE IMMUNE CELLS IN THE INTESTINAL MUCOSA OF IMMUNO-COMPETENT WILD-TYPE MICE
    Wurbel, Marc-Andre
    Peng, Ruoqi
    Erickson, Jamie
    Dunstan, Robert
    Sterman, Annette Schwartz
    Slavin, Anthony
    Kamath, Rajesh
    GASTROENTEROLOGY, 2018, 154 (06) : S1364 - S1364
  • [42] Deficiency Of TGF-β Signaling In CD11c Positive Dendritic Cells, Macrophages And NK Cells Accelerates Atherosclerosis By Inducing Inflammatory Cell Influx
    Lievens, Dirk
    Robertson, Anna-Karin
    Beckers, Linda
    Laouar, Yasmina
    Rudling, Mats
    Biessen, Erik A.
    Daemen, Mat J.
    Flavell, Richard A.
    Lutgens, Esther
    CIRCULATION, 2008, 118 (18) : S510 - S510
  • [43] RETRACTED: Combined therapy using LHRH-PE40 and anti-CD40 dendritic cells substantially eliminate tumor cells (Retracted article. See vol. 123, pg. 495, 2022)
    Zhang, Limin
    Du, TianJiao
    Ma, DongBin
    Guo, Fang
    Li, ZhenWei
    Yan, Hua
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (05) : 8093 - 8100
  • [44] Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence
    Ni, Jing
    Nolte, Britta
    Arnold, Annette
    Fournier, Philippe
    Schirrmacher, Volker
    VACCINE, 2009, 27 (40) : 5480 - 5487
  • [45] Anti-CD40 ab-induced Ig isotype switching of a B-CLL-derived cell line (FH-5) and leukemic cells of chronic B-lymphoid leukemias (B-CLLs).
    Mibukura, T
    Takeuchi, H
    Kayano, H
    Katayama, I
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 472 - 472
  • [46] Control of anti-Leishmania immunity: Suppression by epidermal Langerhans cells versus healing promoted by CD11c+dendritic cells
    Kautz-Neu, K.
    John, D.
    Dinges, S.
    Noordegraaf, M.
    Clausen, B. E.
    vonStebut, E.
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 201 - 201
  • [47] The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy
    Frankish, Jamie
    Mukherjee, Debayan
    Romano, Erminia
    Billian-Frey, Katharina
    Schroder, Matthias
    Heinonen, Karl
    Merz, Christian
    Redondo Mueller, Mauricio
    Gieffers, Christian
    Hill, Oliver
    Thiemann, Meinolf
    Honeychurch, Jamie
    Illidge, Tim
    Sykora, Jaromir
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] C5L2 Deficiency Prevents Prolonged Heart Transplant Survival in Mice Treated With Anti-CD40L mAb.
    Yadav, P.
    Heeger, P.
    TRANSPLANTATION, 2014, 98 : 317 - 317
  • [49] C5L2 Deficiency Prevents Prolonged Heart Transplant Survival in Mice Treated With Anti-CD40L mAb.
    Yadav, P.
    Heeger, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 317 - 317
  • [50] Humanized monoclonal anti-CD40 ligand antibody (hu5c8) rescue therapy of 15 adults with severe chronic refractory ITP.
    Bussel, J
    Wissert, M
    Oates, B
    Scaramucci, J
    Nadeau, K
    Adelman, B
    BLOOD, 1999, 94 (10) : 646A - 646A